Peer Review History
| Original SubmissionApril 5, 2022 |
|---|
|
PONE-D-22-09993Patterns and trends in factors associated with affective and cognitive risk perceptions of COVID-19PLOS ONE Dear Dr. Jang, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Although the reviewers and I found your research question interesting, a number of concerns were raised. The reviewers have provided detailed comments, and I will not reiterate their points. However, an overarching issue is the lack of detail and explanation. With regard to the introduction, a more extensive review of the differences between affective and cognitive risk perception is necessary. What do these constructs differentially predict? Why is it important to examine ARP and CRP separately? Why might this matter in the context of COVID-19? A clear rationale for the study is lacking. For the treatment of variables (e.g., dichotomizing) and analyses, a more detailed description of the analytic strategy should be provided. Also, please provide references supporting your analytic approach. In the results section, it is unclear at times whether descriptions of the data are based on statistical comparisons or observation of the data. Be sure to report all statistical analyses. In the limitations, all of your variables of interest (CRP, ARP, trust in government, political orientation) are measured with single items. This is a shortcoming that needs more attention. This study is also correlational. so causal claims cannot be made. In a few places, causal language is used to discuss the results. This is inappropriate and should be corrected. Please submit your revised manuscript by Sep 08 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Natalie J. Shook Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Please provide additional details regarding participant consent. In the ethics statement in the Methods and online submission information, please ensure that you have specified (1) whether consent was informed and (2) what type you obtained (for instance, written or verbal, and if verbal, how it was documented and witnessed). If your study included minors, state whether you obtained consent from parents or guardians. If the need for consent was waived by the ethics committee, please include this information. If you are reporting a retrospective study of medical records or archived samples, please ensure that you have discussed whether all data were fully anonymized before you accessed them and/or whether the IRB or ethics committee waived the requirement for informed consent. If patients provided informed written consent to have data from their medical records used in research, please include this information. 3. Thank you for stating the following in the Competing Interests section: Jang DH is affiliated with Gallup Korea (https://www.gallup.co.kr/), but did not receive any funding from them for this work. Please confirm that this does not alter your adherence to all PLOS ONE policies on sharing data and materials, by including the following statement: "This does not alter our adherence to PLOS ONE policies on sharing data and materials.” (as detailed online in our guide for authors http://journals.plos.org/plosone/s/competing-interests). If there are restrictions on sharing of data and/or materials, please state these. Please note that we cannot proceed with consideration of your article until this information has been declared. Please include your updated Competing Interests statement in your cover letter; we will change the online submission form on your behalf. 4. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability. "Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized. Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access. We will update your Data Availability statement to reflect the information you provide in your cover letter. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: No Reviewer #2: No ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: No Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Dear authors, Authors have that they have analyze the trends and patterns in associations of two risk perceptions dimensions for COVID-19 —cognitive risk perception and affective risk perception— and their associated factors with a year-long five phase longitudinal design. I have few suggestions to offer. The following are the recommendations that needs attention for this manuscript. Title: "Patterns and trends in factors associated with affective and cognitive risk perceptions of COVID-19", what is meant by pattern and trends, I mean to say, how these two are different from each other. Please explain both in context. Abstract: Be specific in your writing, try to reduce more text in abstract, and use numbers to claim your contributions. Introduction: The Introduction part is badly written. There is no logical flow and almost same things are mentioned repeatedly in haphazard manner. I would suggest the authors improve the introduction section of the article. I will recommend to re-write the introcudtion part and the content should a follow a logical flow. Methods: I am just curious to know if you also take into considertaion about the accessibility of the participants to the daily updates, news, internet. If I missed somewhere please highlight that or else at least discuss that in limitation. My major concern with this study is the sample size and the methods used (lack of spatial analysis for spatial variation). South Korea is a big country with over 51 million people, therefore a sample size of less 23000 for spatial analysis is not reasonable. More importantly, the authors should provide information on the number of participants in each province everytime, like the the survey was conducted 23 times over a period of one year. Results A lot of over interpretation of the results is the major limitation. Conclusion: The conclusion is vague and didn't provide any clear and useful information . It needs to be rewritten Reviewer #2: This study examined the associated predictors of risk perceptions during COVID-19. A multi-faceted approach was used to examine risk taking and a large sample was utilized. The study has some potential for publication but it’s not ready in the current form. More elaboration in the intro and clarification regarding the methodology is needed. I present my detailed comments below in the order of appearance in the text. Abstract. “associated factors” is a vague term. There should be at least some reasoning for why these factors are associated. I comment more on this in the introduction. p5 l78. “10 Asian, American, and European” what is the distribution of these 10 countries according to continents. p5 l85. What is the justification for choosing a factor as “key”? You should elaborate more on why you choose specific factors and why you expected them to be associated. If there is a theoretical basis of these choices it should also be explained. Currently, the study is atheoretical and there is no solid background for why these factors are studied. p5 l88. Do you expect significant differences between the five-phases? If yes, how? If not, what may this exploration show us in the end? p5 l89. You’ve presented the details for the five phases in Table S2. I think these phases are an essential part of the study and possibly unfamiliar to non-Korean readers. Adding the necessary details in text would be helpful. p5 l92. “related factors” as said this is vague term and I don’t see any reasoning for why only the factors that are present in the parentheses are chosen. These should have been introduced with justifications earlier. p6 l101. This info on current standing of the literature should be presented earlier in the introduction. p6 l115. So each survey actually has different samples, which makes over 23,000 people in total. From the abstract my first impression was that 23,000 people participated in 23 waves of the study. This should be clearly explained in the abstract. Further, this is the first time I’ve encountered a design like this. For me to evaluate the following versions of the manuscript better I’d appreciate if the authors can include some example papers. Including these examples in text may also be helpful for the reader since this may not be common for many readers as well. p7 l119. Please add the info that the descriptive information can be found at Table S3. p7 l121. Instead of “potentially associated factors” it can be better to divide this as “demographics” and “political characteristics”. Then list them under a “measures” title along with the measured of “Risk perception”. p7 l125. Why was age divided this way? p7 l131. Why were these demographics chosen? For example, why is education not included? p8 l142. Why were these scores combined and not used as a continuous measure? p8 l145. This essential info should be presented in the introduction. p8 l148. Are these confirmed cases based on the location of the participants or the whole country? p9 l164. Are these percentages of people who perceived risk? p15 l183. Add the indication that these are pooled analysis in the first place you start explaining the analysis. p15 l 185. If the results are not statistically significant i don’t think they should be mentioned. They may raise more confusion. p15 l188. I do not have expertise on this type of analysis and a question. You report that women’s ARP change over time according to the p-value of the test of homogeneity of aORs. How do you define that this is due to Phase 4 being lower than other phases? Did you test for differences between phases or is this just an interpretation based on the aORs? Also for your confidence intervals you mid-point is not 0. This is also something I’m not used to. I'm not sure if this is a typo or a way of reporting that I'm used to. If it is a typo it should be fixed, if not it would be great to add in notes for what the mid point of the intervals are. p19 l223. The other way around may also be present. Strong emotional responses may be provoking distrust towards the government. Did you test this possible other direction? p21 l259. How the listed limitation actually limited should be explained. For example not including education level is listed as a limitation, but you did not explain how did this actually limited your study. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Dr Junaid Ahmad Reviewer #2: Yes: Barış Sevi ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
PONE-D-22-09993R1The Association among Risk Perceptions of COVID-19, Trust in Government, Political Ideology, and Socio-Demographic Factors: A Year Consecutive Cross-Sectional Study in South Korea.PLOS ONE Dear Dr. Jang, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please see Reviewer 2's comments. Please submit your revised manuscript by Jan 15 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Natalie J. Shook Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: I Don't Know ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: No ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Thank you for revising the manuscript. I think the comments are addressed very well. Thank you for giving us the opportunity to review the revised draft of your manuscript titled “The Association among Risk Perceptions of COVID-19, Trust in Government, PoliticalIdeology, and Socio-Demographic Factors: A Year Consecutive Cross-Sectional Study in South Korea”. I don't have any more commments. Reviewer #2: I thank the authors for addressing my comments. The manuscript looks much improved. I have a few more comments taht I believe will help the manuscript improve even more. P8L147. Not sure "Factors that were potentially associated with both dimensions of risk perception included sociodemographic factors, trust in the government, and political ideology." this sentence belong under the subtitle demographics. Maybe it should have come right after the Measures title. P8L157. Since you are asking about the current president and not asking about general attitudes towards government it would be more appropriate to label this variable as "Trust in current government". This point may also be discussed in the discussion section. Results. The analyses plan explains what analyses are conducted. However mentioning the name of the type of tests you conducted before reporting the results would be helpful for readers who are not custom to your analyses. For example you report a p value at p10l203, but it's not clear what test is used. You can also add this info at the tables, I think it would be very helpful for the readers. Table 1. The label "Presidential job approval rating" is not consistent with how you labeled this variable in your measures. Table 3&4. At table 2 you indicated the reference variables, this was not done at Tables 3 and 4. Is there a reason for this difference? If not I think it helps to include that indication. Overall comment. Labels of gender (men, women) and sex (male, female) are used interchangeably. Please be consistent on the use of this variable. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Junaid Ahmad Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
The association between the risk perceptions of COVID-19, trust in government, political ideologies, and socio-demographic factors: A year-long cross-sectional study in South Korea. PONE-D-22-09993R2 Dear Dr. Jang, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Natalie J. Shook Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-22-09993R2 The association between the risk perceptions of COVID-19, trust in the government, political ideologies, and socio-demographic factors: A year-long cross-sectional study in South Korea. Dear Dr. Jang: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Natalie J. Shook Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .